EBITDA: Income before interest, taxes, depreciation and amortization.
Senti Biosciences, Inc. (SNTI) had EBITDA of $-3.93M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.02M |
|
$-4.22M |
|
-- |
|
$0.02M |
|
$4.63M |
|
$-4.62M |
|
$0.40M |
|
$-4.22M |
|
$-4.22M |
|
$-4.22M |
|
$-4.22M |
|
$-4.22M |
|
$-4.22M |
|
$-4.62M |
|
|
EBITDA |
$-3.93M |
30.97M |
|
30.97M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$14.79M |
|
$12.10M |
|
$23.45M |
|
$38.24M |
|
$14.27M |
|
-- |
|
$21.41M |
|
$35.68M |
|
$2.56M |
|
$2.56M |
|
$2.56M |
|
31.14M |
|
| Cash Flow Statement Financials | |
$-7.48M |
|
$0.11M |
|
$-0.12M |
|
$19.95M |
|
$12.46M |
|
$-7.49M |
|
$1.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-28850.00% |
|
-28850.00% |
|
-- |
|
-26381.25% |
|
-26381.25% |
|
$-7.37M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.02 |
|
4303.12 |
|
-164.56% |
|
-164.56% |
|
-11.04% |
|
-164.56% |
|
$0.08 |
|
$-0.24 |
|
$-0.24 |
|